This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

DMC Heart Care Specialists Are First In Midwest To Implement "Robotic-Assisted" Revascularization To Relieve Arterial Blockages

Major breakthrough at DMC Cardiovascular Institute will revolutionize treatment for heart patients with coronary blood-flow disorders, says CVI President Theodore L. Schreiber, M.D.  

DETROIT, Jan. 8, 2013 /PRNewswire-USNewswire/ -- The Detroit Medical Center (DMC) announced today that a team of heart specialists at its Cardiovascular Institute (CVI) has successfully conducted the Midwest's first-ever "robotic-assisted" coronary revascularization to relieve heart artery blockages.  The successful implementation of the pioneering new treatment procedure – unique in Michigan and so far performed at only three institutions in the United States – means that DMC heart care patients now have access to the world's most advanced treatment method for relieving  blockages in heart arteries, said CVI President Theodore L. Schreiber, M.D.

(Photo - http://photos.prnewswire.com/prnh/20130108/DC39253)

"This is a major step forward for heart care patients in Michigan and the Midwest," said Dr. Schreiber, while describing Monday's successful implementation of the robotic-assisted angioplasty procedure at the DMC CVI.  "What it means is that many DMC heart patients can now enjoy the benefits of the world's most advanced and proven technology for removing blockages in arteries that feed the heart.

"Thanks to the remarkably precise arterial navigation advances and the enhanced visualization provided by robotic-assisted revascularization, clinicians will now be able to help heart patients with significantly advanced techniques for using stents or balloons to relieve arterial blockages.  These advances will often lead to better patient outcomes – and I don't think it's an exaggeration to suggest that this is the dawn of a new era in heart care.  Once again, the Detroit Medical Center and the Cardiovascular Institute are leading the way in pioneering a new treatment method that will help heart patients to get better as quickly and painlessly as possible."

1 of 3

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
SYM TRADE IT LAST %CHG

Markets

DOW 18,154.18 +112.64 0.62%
S&P 500 2,119.22 +15.02 0.71%
NASDAQ 5,080.3030 +47.5520 0.94%

Partners Compare Online Brokers

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs